Samumed Revenue and Competitors
Estimated Revenue & Valuation
- Samumed's estimated annual revenue is currently $36.4M per year.
- Samumed received $440.0M in venture funding in November 2018. 0
- Samumed's total funding is $778M.
- Samumed's current valuation is $12B.
Employee Data
- 00
Samumed Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.7M | 51 | 2% | $53M | N/A |
#2 | $34.3M | 177 | 17% | $110M | N/A |
#3 | $0.4M | 273 | 5% | $236.7M | N/A |
#4 | $34.5M | 114 | -23% | $160M | N/A |
#5 | $3.7M | 24 | 20% | N/A | N/A |
#6 | $147.3M | 321 | 2% | $192.5M | N/A |
#7 | $17.5M | 113 | -3% | $24.1M | N/A |
#8 | $2.7M | 43 | 79% | N/A | N/A |
#9 | $34.1M | 220 | 100% | N/A | N/A |
#10 | $47.1M | 304 | -3% | N/A | N/A |
What Is Samumed?
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
keywords:Biotechnology,Customer Support,Education,Healthcare,Human Resources Hr,Pharmaceuticals$778M
Total Funding
N/A
Number of Employees
$36.4M
Revenue (est)
N/A
Employee Growth %
$12B
Valuation
N/A
Accelerator
Samumed News
Osman Kibar, founder and CEO of biotech firm Samumed, with $2.3 billion. 1397. Phillip Frost, a long-time health care investor and founder,...
Founded in 2008, Samumed has spent most of its lifetime working under the radar. It came out of the shadows in 2016 with a war chest of $220 ...
Founded in 2008, Samumed has spent most of its lifetime working under the radar. It came out of the shadows in 2016 with a war chest of $220 million drawn from investors including Ikea’s private venture arm and some very wealthy individuals along with a pipeline of drugs it says can reverse agin ...
SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has finalized the design of its phase 3 clinical ...
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has successfully completed an End-of-Phase 2 ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18M | 0 | N/A | $168.6M |
#2 | $22.7M | 0 | N/A | N/A |
#3 | $8.4M | 0 | N/A | N/A |
#4 | $11.7M | 0 | N/A | $4.4M |
#5 | $1.7M | 0 | N/A | N/A |
Samumed Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-08-07 | $438.0M | A-6 | Article | |
2018-11-27 | $440.0M | A | Vickers Venture Partners | Article |